Literature DB >> 2775321

Normotensive renal failure in systemic sclerosis.

D J Helfrich1, B Banner, V D Steen, T A Medsger.   

Abstract

Of 140 patients with "scleroderma renal crisis" encountered during a 33-year period, 15 of 131 (11%) whose blood pressures were recorded were normotensive during this complication. In comparison with 116 patients with hypertension, the normotensive patients significantly more often had microangiopathic hemolytic anemia (90% versus 38%) and thrombocytopenia (83% versus 21%). Pulmonary hemorrhage occurred in 6 normotensive patients. More normotensive patients had received high doses of corticosteroids (prednisone greater than or equal to 30 mg/day) during the 2 months immediately preceding renal crisis (64% versus 16%). A role for corticosteroids in precipitating renal crisis is suggested. The 12-month survival was significantly reduced in the normotensive patients (13% versus 35%).

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2775321     DOI: 10.1002/anr.1780320911

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  37 in total

Review 1.  Scleroderma renal crisis: new insights and developments.

Authors:  Elisa Y Rhew; Walter G Barr
Journal:  Curr Rheumatol Rep       Date:  2004-04       Impact factor: 4.592

Review 2.  Old medications and new targeted therapies in systemic sclerosis.

Authors:  Vivek Nagaraja; Christopher P Denton; Dinesh Khanna
Journal:  Rheumatology (Oxford)       Date:  2014-07-26       Impact factor: 7.580

Review 3.  [Systemic sclerosis : What is currently available for treatment?]

Authors:  M O Becker
Journal:  Internist (Berl)       Date:  2016-12       Impact factor: 0.743

4.  Intravenous dexamethasone pulse therapy in diffuse systemic sclerosis. A randomized placebo-controlled study.

Authors:  B Sharada; A Kumar; R Kakker; C M Adya; I Pande; S S Uppal; J N Pande; K R Sunderam; A N Malaviya
Journal:  Rheumatol Int       Date:  1994       Impact factor: 2.631

Review 5.  [Renal manifestations of rheumatic diseases].

Authors:  A Schwarting; E Märker-Hermann
Journal:  Z Rheumatol       Date:  2005-02       Impact factor: 1.372

Review 6.  Scleroderma renal crisis: a rare but severe complication of systemic sclerosis.

Authors:  Luc Mouthon; Alice Bérezné; Guillaume Bussone; Laure-Hélène Noël; Peter M Villiger; Loïc Guillevin
Journal:  Clin Rev Allergy Immunol       Date:  2011-04       Impact factor: 8.667

7.  Renal manifestations in scleroderma: evidence for subclinical renal disease as a marker of vasculopathy.

Authors:  Victoria K Shanmugam; Virginia D Steen
Journal:  Int J Rheumatol       Date:  2010-08-17

8.  Microscopic polyangiitis in systemic sclerosis.

Authors:  Hiroshi Hashimoto
Journal:  Int J Rheumatol       Date:  2010-08-09

Review 9.  Determinants of mortality in systemic sclerosis: a focused review.

Authors:  Dilli Ram Poudel; Divya Jayakumar; Abhijeet Danve; Shiv Tej Sehra; Chris T Derk
Journal:  Rheumatol Int       Date:  2017-11-07       Impact factor: 2.631

Review 10.  A "silent" course of normotensive scleroderma renal crisis: case report and review of the literature.

Authors:  Hadim Akoglu; Gokhan Kadir Atilgan; Ramazan Ozturk; Ezgi Coskun Yenigun; Ipek Isik Gonul; Ali Riza Odabas
Journal:  Rheumatol Int       Date:  2008-12-02       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.